Cystic Fibrosis Medicines in India: CFTR Modulators and Inhaled Treatments
What goes wrong in cystic fibrosis
CF is inherited. A child gets it only when both parents pass on a faulty copy of the CFTR gene. The CFTR protein normally moves salt and water across the lining of the lungs, gut, pancreas and sweat glands. When it fails, mucus turns thick and sticky. In the lungs this traps germs, which leads to repeated chest infections and, over time, permanent widening of the airways (bronchiectasis). In the pancreas it blocks the enzymes needed to digest food, so children gain weight poorly and pass oily stools.
In the Indian multicentre study, the commonest complaints at diagnosis were a long-lasting cough (89.5%), poor growth (76.9%) and chronic diarrhoea (62.3%). By the time the diagnosis was made, a chest CT already showed bronchiectasis in 90% of the children [1].
Why the gene report matters more for Indian patients
Most CF guides are written for European families, where the F508del change is found on most CF gene copies. Indian data look different. Among 260 children tested at AIIMS New Delhi, AIIMS Jodhpur, SKIMS Srinagar and CMC Vellore, researchers found 105 different CFTR variants, 14 of them never reported before, and F508del made up only about a third of CF gene copies in each region [2]. Each region had its own handful of common variants, and the pattern in southern and eastern India resembled West Asia more than Europe [2].
This matters for treatment because CFTR modulators work only when at least one gene copy carries a variant that responds to them. Two variants reported in Indian children, 3849+10kbC>T (a common variant group in the multicentre study [3]) and V456A (the second most common variant at a Mumbai children's hospital [5]), are both named in the list of responsive variants in the current US label for Trikafta [7]. A full CFTR gene report, not just a test for F508del, is what lets your doctor check eligibility.
| Treatment group | What it does | Medicines on this page |
|---|---|---|
| CFTR modulator | Helps the faulty CFTR protein reach the cell surface and open, treating the cause rather than the symptoms | Trikafta, Kaftrio |
| Mucus thinner | An inhaled enzyme that breaks down DNA in thick sputum so it is easier to cough out | Pulmozyme |
| Inhaled antibiotic | Delivers an antibiotic straight into the airways for long-term Pseudomonas infection | Quinsair |
Imported cystic fibrosis medicines by type
All 4 medicines below are prescription-only. Tap a type to filter. Each card opens the full medicine page with dosage, storage and safety details.




Compare all 4 cystic fibrosis medicines
| Medicine | Generic name | Cystic fibrosis type | Form | Approved by |
|---|---|---|---|---|
| Trikafta | elexacaftor + tezacaftor + ivacaftor | CFTR modulator | Tablet | US FDA |
| Kaftrio | elexacaftor + tezacaftor + ivacaftor | CFTR modulator | Tablet | EMA (Europe) |
| Pulmozyme | dornase alfa | Mucus thinner | Inhalation solution (nebuliser) | US FDA |
| Quinsair | levofloxacin | Inhaled antibiotic | Inhalation solution (nebuliser) | EMA (Europe), Health Canada |
Tests to have ready before treatment
| Report | What it tells the doctor | Relevant medicines |
|---|---|---|
| Sweat chloride test | The standard test that confirms CF. In a Mumbai series it was clearly positive in 46 of 58 children and borderline in 9, so some patients also need a gene test to settle the diagnosis [5] | All medicines here |
| Full CFTR gene report (both copies) | Trikafta needs at least one responsive variant or one that makes CFTR protein; Kaftrio in Europe needs at least one variant that is not Class I | Trikafta, Kaftrio |
| Sputum or throat swab culture | Shows whether Pseudomonas aeruginosa has settled in the lungs long term | Quinsair |
| Lung function (spirometry) and liver tests | Tracks response to treatment; liver tests are checked before and during CFTR modulator treatment as per the label | Trikafta, Kaftrio, Pulmozyme |
Where a sweat test is hard to get, an Indian team has built a bedside score from simple clues such as a sibling with CF, clubbing, low blood sodium and Pseudomonas in sputum, so treatment can begin while confirmation is awaited [6]. It does not replace the sweat or gene test.
Import permission, cold storage and long-term cost
Because these medicines are imported for one person, the Form 12A request to CDSCO is filed by the patient, with our pharmacist filling in the paperwork, and the import can go ahead once CDSCO grants the Form 12B permit. Every document a family needs to send is listed in our import permit checklist.
Pulmozyme ampules have to be kept refrigerated at 2–8 °C, even while in transit [8], so we hand them to the treating hospital's pharmacy through our cold-chain hospital delivery service. CFTR modulators are usually taken every day for life, so families should plan the cost early; our patient support and access programs page covers company-run assistance, state and central schemes, and charities worth contacting.
How to get these cystic fibrosis medicines in India
Prescription
Your doctor prescribes the medicine.
Share documents
Send the prescription and latest reports through Online Order.
Import paperwork
Our team checks the source and the import permissions.
Delivery
Delivered with the right storage, including cold chain.
Read How to Order and Indian import regulations. We also serve patients in Delhi NCR, Bangalore, Chennai, Mumbai, Kolkata, Hyderabad and Pune.
Has your doctor prescribed one of these medicines?
Share the prescription and we will guide you on availability and next steps.
Read more about cystic fibrosis
References
- Bhat JI, Dhochak N, Kumar P, et al. Clinical Profile of Cystic Fibrosis in India: A Multi-Centric Prospective Study. J Paediatr Child Health. 2026;62(7):1178-1185. https://pubmed.ncbi.nlm.nih.gov/42108567/
- Chowdhury MR, Kumari I, Jat KR, et al. Profile of CFTR gene variants across India and their variability in different geographic regions. Gene. 2026;976:149870. https://pubmed.ncbi.nlm.nih.gov/41203217/
- Jat KR, Chowdhury MR, Dhochak N, et al. Genotype-Phenotype Correlation in Children With Cystic Fibrosis From India: A Multicentric Study. Clin Genet. 2026;109(3):481-489. https://pubmed.ncbi.nlm.nih.gov/40963488/
- Kumar P, Goyal JP, Bhat JI, et al. Microbiological Profile of Airway in Indian Children With Cystic Fibrosis: A Multicenter Prospective Cohort Study. Pediatr Pulmonol. 2025;60(7):e71194. https://pubmed.ncbi.nlm.nih.gov/40693575/
- Chandane P, Chauhan A, Bhosale A, et al. Clinical and genetic profiles of paediatric patients with cystic fibrosis from Western India. Lung India. 2025;42(2):103-108. https://pubmed.ncbi.nlm.nih.gov/40013628/
- Dhochak N, Lodha R, Jat KR, et al. Diagnostic accuracy of ancillary tests in diagnosis of cystic fibrosis and development of a CF clinical diagnostic score. Respir Med. 2025;242:108087. https://pubmed.ncbi.nlm.nih.gov/40189161/
- US FDA prescribing information: Trikafta (elexacaftor, tezacaftor and ivacaftor), DailyMed. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f354423a-85c2-41c3-a9db-0f3aee135d8d
- US FDA prescribing information: Pulmozyme (dornase alfa), DailyMed. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d8c78a7e-ff99-48f3-8952-643ec2ea0f86
- European Medicines Agency. Kaftrio – EPAR overview and therapeutic indication. https://www.ema.europa.eu/en/medicines/human/EPAR/kaftrio
- European Medicines Agency. Quinsair – EPAR overview and therapeutic indication. https://www.ema.europa.eu/en/medicines/human/EPAR/quinsair
This page gives general information only and does not replace medical advice. All medicines listed are prescription-only and must be used under a qualified doctor.